| Autor: |
Kumagai J; Division of Dermatology, Hyogo Prefectural Kakogawa Medical Center., Adachi A; Division of Dermatology, Hyogo Prefectural Kakogawa Medical Center., Nagahama M; Division of Dermatology, Hyogo Prefectural Kakogawa Medical Center., Yamada H; Division of Dermatology, Hyogo Prefectural Kakogawa Medical Center., Masuda Y; Division of Dermatology, Hyogo Prefectural Kakogawa Medical Center., Kitamura H; Seirei-Awaji Hospital. |
| Jazyk: |
japonština |
| Zdroj: |
Arerugi = [Allergy] [Arerugi] 2023; Vol. 72 (5), pp. 479-484. |
| DOI: |
10.15036/arerugi.72.479 |
| Abstrakt: |
A woman in her 20s presented to our clinic with a lower gastrointestinal infection. When we administered intravenous antibacterial and vitamin infusions, she developed anaphylaxis. We performed skin tests to investigate the cause, and an intradermal test was positive for a 1% intravenous vitamin complex. We then performed a component-specific test, which was positive for thiamine disulfide phosphate, a vitamin B1 derivative. We therefore diagnosed anaphylaxis due to thiamine disulfide phosphate. No previous reports have described cross-reactivity between vitamin B1 derivatives. In our case, however, the patient tested positive for fluthiamine hydrochloride, suggesting cross-reactivity. Intravenous vitamin complexes are used in daily clinical practice and should be administered with caution because of the possibility of anaphylaxis, although it occurs infrequently. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
